A novel role of globular adiponectin in treatment with HFD/STZ induced T2DM combined with NAFLD rats

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Ma, Hong ^a,b   You, Guo Ping ^a,b   Zhang, Xuan Pu ^a,b   Yang, Xiang Jiu ^a   Lu, Hua Dong ^a   Huang, Yan Ling ^a   Zhang, Wen Qiang ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; GLOBULAR ADIPONECTIN; UNCLASSIFIED DRUG; ADIPONECTIN RECEPTOR; STREPTOZOCIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FATTY LIVER; INSULIN RELEASE; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; DRUG EFFECTS; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; WISTAR RAT;

ADIPONECTIN; ANIMALS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER; MALE; MUSCLE, SKELETAL; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS; RATS, WISTAR; RECEPTORS, ADIPONECTIN; STREPTOZOCIN; TREATMENT OUTCOME;

EID: 84896872189     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/230835     Document Type: Article

References (29)

1. Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L., Day C., Arcaro G., Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007 30 5 1212 1218 2-s2.0-34247605492 10.2337/dc06-2247
2. Williamson R. M., Price J. F., Glancy S., Perry E., Nee L. D., Hayes P. C., Frier B. M., Van Look L. A. F., Johnston G. I., Reynolds R. M., Strachan M. W. J., Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care 2011 34 5 1139 1144 2-s2.0-79956062113 10.2337/dc10-2229
3. Targher G., Byrne C. D., Clinical Review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. Journal of Clinical Endocrinology and Metabolism 2013 98 2 483 495 10.1210/jc.2012-3093
4. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 2006 116 7 1784 1792 2-s2.0-33745834319 10.1172/JCI29126
5. Hivert M. F., Sullivan L. M., Fox C. S., Nathan D. M., D'Agostino R. B. Sr., Wilson P. W. F., Meigs J. B., Associations of adiponectin, resistin, and tumor necrosis factor- α with insulin resistance. Journal of Clinical Endocrinology and Metabolism 2008 93 8 3165 3172 2-s2.0-49249138836 10.1210/jc.2008-0425
6. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 1 79 83 2-s2.0-0033515761 10.1006/bbrc.1999.0255
7. Li S., Shin H. J., Ding E. L., Van Dam R. M., Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association 2009 302 2 179 188 2-s2.0-67650169799 10.1001/jama.2009.976
8. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., Eto K., Yamashita T., Kamon J., Satoh H., Yano W., Froguel P., Nagai R., Kimura S., Kadowaki T., Noda T., Disruption of adiponectin causes insulin resistance and neointimal formation. Journal of Biological Chemistry 2002 277 29 25863 25866 2-s2.0-0037135523 10.1074/jbc.C200251200
9. Fruebis J., Tsao T., Javorschi S., Ebbets-Reed D., Erickson M. R. S., Yen F. T., Bihain B. E., Lodish H. F., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proceedings of the National Academy of Sciences of the United States of America 2001 98 4 2005 2010 2-s2.0-0035852760 10.1073/pnas.041591798
10. Kim J. Y., van de Wall E., Laplante M., Azzara A., Trujillo M. E., Hofmann S. M., Schraw T., Durand J. L., Li H., Li G., Jelicks L. A., Mehler M. F., Hui D. Y., Deshaies Y., Shulman G. I., Schwartz G. J., Scherer P. E., Obesity-associated improvements in metabolic profile through expansion of adipose tissue. Journal of Clinical Investigation 2007 117 9 2621 2637 2-s2.0-34848872799 10.1172/JCI31021
11. Berg A. H., Combs T. P., Du X., Brownlee M., Scherer P. E., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 2001 7 8 947 953 2-s2.0-0034881391 10.1038/90992
12. Kadowaki T., Yamauchi T., Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 3 439 451 2-s2.0-18844432308 10.1210/er.2005-0005
13. Tsuchida A., Yamauchi T., Ito Y., Hada Y., Maki T., Takekawa S., Kamon J., Kobayashi M., Suzuki R., Hara K., Kubota N., Terauchi Y., Froguel P., Nakae J., Kasuga M., Accili D., Tobe K., Ueki K., Nagai R., Kadowaki T., Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. Journal of Biological Chemistry 2004 279 29 30817 30822 2-s2.0-3142701401 10.1074/jbc.M402367200
14. Debard C., Laville M., Berbe V., Loizon E., Guillet C., Morio-Liondore B., Boirie Y., Vidal H., Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients. Diabetologia 2004 47 5 917 925 2-s2.0-2942622680 10.1007/s00125-004-1394-7
15. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., Okada-Iwabu M., Kawamoto S., Kubota N., Kubota T., Ito Y., Kamon J., Tsuchida A., Kumagai K., Kozono H., Hada Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Awazawa M., Takamoto I., Froguel P., Hara K., Tobe K., Nagai R., Ueki K., Kadowaki T., Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Medicine 2007 13 3 332 339 2-s2.0-33847733103 10.1038/nm1557
16. Bjursell M., Ahnmark A., Bohlooly-Y M., William-Olsson L., Rhedin M., Peng X., Ploj K., Gerdin A., Arnerup G., Elmgren A., Berg A., Oscarsson J., Lindén D., Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 2007 56 3 583 593 2-s2.0-33847385075 10.2337/db06-1432
17. Inukai K., Nakashima Y., Watanabe M., Takata N., Sawa T., Kurihara S., Awata T., Katayama S., Regulation of adiponectin receptor gene expression in diabetic mice. American Journal of Physiology 2005 288 5 E876 E882 2-s2.0-17444411871 10.1152/ajpendo.00118.2004
18. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., Sugiyama T., Miyagishi M., Kara K., Tsunoda M., Murakami K., Ohteki T., Uchida S., Takekawa S., Waki H., Tsuno N. H., Shibata Y., Terauchi Y., Froguel P., Tobe K., Koyasu S., Taira K., Kitamura T., Shimizu T., Nagai R., Kadowaki T., Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003 423 762 769 2-s2.0-19644401011 10.1038/nature03091
19. Ceddia R. B., Somwar R., Maida A., Fang X., Bikopoulos G., Sweeney G., Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 2005 48 1 132 139 2-s2.0-12944302597 10.1007/s00125-004-1609-y
20. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M. L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001 7 8 941 946 2-s2.0-17944365228 10.1038/90984
21. Fan J. G., Jia J. D., Li Y. M., Wang B. Y., Lu L. G., Shi J. P., Chan L. Y., Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010: (Published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166) JG Fan etal. Diagnosis and management of NAFLD. Journal of Digestive Diseases 2011 12 1 38 44 2-s2.0-79251581867 10.1111/j.1751-2980.2010. 00476.x
22. Zheng X. K., Zhang L., Wang W. W., Wu Y. Y., Zhang Q. B., Feng W. S., Anti-diabetic activity and potential mechanism of total flavonoids of Selaginella tamariscina (Beauv.) Spring in rats induced by high fat diet and low dose STZ. Journal of Ethnopharmacology 2011 137 1 662 668 2-s2.0-80052034594 10.1016/j.jep.2011.06.018
23. Mathis D., Vence L., Benoist C., β -cell death during progression to diabetes. Nature 2001 414 6865 792 798 2-s2.0-0035856952 10.1038/414792a
24. Sinacore D. R., Gulve E. A., The role of skeletal muscle in glucose transport, glucose homeostasis, and insulin resistance: implications for physical therapy. Physical Therapy 1993 73 12 878 891 2-s2.0-0027383816
25. Hulver M. W., Berggren J. R., Cortright R. N., Dudek R. W., Thompson R. P., Pories W. J., MacDonald K. G., Cline G. W., Shulman G. I., Dohm G. L., Houmard J. A., Skeletal muscle lipid metabolism with obesity. American Journal of Physiology 2003 284 4 E741 E747 2-s2.0-0037376854
26. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B. B., Kadowaki T., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002 8 11 1288 1295 2-s2.0-0036851817 10.1038/nm788
27. Myeong J. Y., Gha Y. L., Chung J., Young H. A., Seung H. H., Jae B. K., Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor{alpha}. Diabetes 2006 55 9 2562 2570 2-s2.0-33750578279 10.2337/db05-1322
28. Beylot M., Pinteur C., Peroni O., Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats. Metabolism 2006 55 3 396 401 2-s2.0-32544444861 10.1016/j.metabol.2005.09.016
29. Staiger H., Kaltenbach S., Staiger K., Stefan N., Fritsche A., Guirguis A., Péterfi C., Weisser M., Machicao F., Stumvoll M., Häring H., Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes 2004 53 9 2195 2201 2-s2.0-4344713648 10.2337/diabetes.53.9.2195